Ranjit Ray
Overview
Explore the profile of Ranjit Ray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
3196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haga Y, Ray R, Ray R
Mol Carcinog
. 2024 Oct;
64(1):72-82.
PMID: 39377735
The rising incidence of hepatocellular carcinoma (HCC) is a global problem. Several approved treatments, including immune therapy and multi-tyrosine kinase inhibitors, are used for treatment, although the results are not...
2.
Haga Y, Coates S, Ray R
Mol Aspects Med
. 2024 Aug;
99:101305.
PMID: 39167987
Hepatitis C virus (HCV) infection is a major health problem worldwide. It can cause liver cirrhosis and hepatocellular carcinoma (HCC), making it a cause of morbidity from liver disease. Thus,...
3.
Haga Y, Bandyopadhyay D, Khatun M, Tran E, Steele R, Banerjee S, et al.
J Biol Chem
. 2024 Mar;
300(5):107247.
PMID: 38556083
There is a critical need to understand the disease processes and identify improved therapeutic strategies for hepatocellular carcinoma (HCC). The long noncoding RNAs (lncRNAs) display diverse effects on biological regulations....
4.
Haga Y, Meyer K, Sung M, Reagan E, Weissman D, Ray R
J Virol
. 2023 Dec;
98(1):e0180923.
PMID: 38084956
The rational selection of hepatitis C virus (HCV) vaccine antigen will aid in the prevention of future chronic liver disease burden and associated healthcare costs. We have previously shown that...
5.
Patra T, Meyer K, Haga Y, Reagan E, Weissman D, Ray R
NPJ Vaccines
. 2023 Mar;
8(1):42.
PMID: 36934116
Hepatitis C virus (HCV) is characterized by a high number of chronic cases due to an impairment of protective innate and adaptive immune responses. Here, we examined the contribution of...
6.
Patra T, Cunningham D, Meyer K, Toth K, Ray R, Heczey A, et al.
Mol Ther
. 2023 Jan;
31(3):715-728.
PMID: 36609146
Overexpression of Lin28 is detected in various cancers with involvement in the self-renewal process and cancer stem cell generation. In the present study, we evaluated how the Lin28 axis plays...
7.
Patra T, Ray R
J Inflamm (Lond)
. 2022 Dec;
19(1):28.
PMID: 36585712
Background: Hypercoagulable state and thromboembolic complications are potential life-threatening events in COVID-19 patients. Our previous studies demonstrated that SARS-CoV-2 infection as well as viral spike protein expressed epithelial cells exhibit...
8.
Sasaki-Tanaka R, Ray R, Moriyama M, Ray R, Kanda T
Int J Mol Sci
. 2022 Sep;
23(17).
PMID: 36077080
Alcohol is the one of the major causes of liver diseases and promotes liver cirrhosis and hepatocellular carcinoma (HCC). In hepatocytes, alcohol is converted to acetaldehyde, which causes hepatic steatosis,...
9.
Vijayamahantesh V, Patra T, Meyer K, Alameh M, Reagan E, Weissman D, et al.
J Virol
. 2022 May;
96(12):e0052322.
PMID: 35612312
Hepatitis C virus (HCV) is characterized by a high number of chronic cases owing to an impairment of innate and adaptive immune responses. CD81 on the cell surface facilitates HCV...
10.
Sur S, Steele R, Isbell T, Ray R, Ray R
mBio
. 2022 May;
13(3):e0095122.
PMID: 35587188
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces inflammatory response, cytokine storm, venous thromboembolism, coagulopathy, and multiple organ damage. Resting endothelial cells prevent coagulation, control blood flow, and inhibit...